Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
第一作者:
Charles,Lu
第一单位:
Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
作者:
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);活组织检查, 针吸(Biopsy, Needle);化学疗法, 肿瘤, 局部灌注(Chemotherapy, Cancer, Regional Perfusion);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);药物载体(Drug Carriers);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);免疫组织化学(Immunohistochemistry);脂质体(Liposomes);男(雄)性(Male);间皮瘤(Mesothelioma);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);胸膜肿瘤(Pleural Neoplasms);概率(Probability);危险性评估(Risk Assessment);存活率(Survival Rate);胸腔镜检查(Thoracoscopy);治疗结果(Treatment Outcome)
DOI
10.1200/JCO.2005.00.802
PMID
15908659
发布时间
2007-11-14
- 浏览353
Journal of clinical oncology
3495-501页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



